Iterum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITRM and other ETFs, options, and stocks.About ITRM
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N.
CEOCorey N. Fishman
CEOCorey N. Fishman
Employees9
Employees9
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2015
Founded2015
Employees9
Employees9
ITRM Key Statistics
Market cap23.77M
Market cap23.77M
Price-Earnings ratio-0.63
Price-Earnings ratio-0.63
Dividend yield—
Dividend yield—
Average volume834.22K
Average volume834.22K
High today$0.4911
High today$0.4911
Low today$0.4352
Low today$0.4352
Open price$0.47
Open price$0.47
Volume622.59K
Volume622.59K
52 Week high$3.02
52 Week high$3.02
52 Week low$0.3622
52 Week low$0.3622
Stock Snapshot
As of today, Iterum Therapeutics(ITRM) shares are valued at $0.45. The company's market cap stands at 23.77M, with a P/E ratio of -0.63.
On 2025-12-08, Iterum Therapeutics(ITRM) stock traded between a low of $0.44 and a high of $0.49. Shares are currently priced at $0.45, which is +3.4% above the low and -8.4% below the high.
The Iterum Therapeutics(ITRM)'s current trading volume is 622.59K, compared to an average daily volume of 834.22K.
During the past year, Iterum Therapeutics(ITRM) stock moved between $0.36 at its lowest and $3.02 at its peak.
During the past year, Iterum Therapeutics(ITRM) stock moved between $0.36 at its lowest and $3.02 at its peak.
People also own
Based on the portfolios of people who own ITRM. This list is generated using Robinhood data, and it’s not a recommendation.